Substance

ID:1824873

Names and Identifiers
IUPAC name
(4R,5S,6S)-3-{[(3S,5S)-5-[(3-carboxyphenyl)carbamoyl]pyrrolidin-3-yl]sulfanyl}-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
Synonyms
ertapenem(1R,5S,6S,8R,2'S,4'S)-2-(2-(3-carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid(4R,5S,6S)-3-((3S,5S)-5-((3-carboxyphenyl)carbamoyl)pyrrolidin-3-ylthio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acidERTAPENEM
International Nonproprietary Name (INN)
ertapenem
IUPAC Traditional name
ertapenem
Registration numbers
PubChem CID
150610
CAS Number
153832-46-3
ACToR Database
153832-46-3
BKMS React Database
3762
BRENDA Ligand Database
3762
CompTox Database
DTXSID50165456
SABIO-RK Database
11946
SureChEMBL Database
SCHEMBL34454
Beilstein Number
9025520
Wikipedia Title
Ertapenem
Patent number
WO9315078US5478820
DrugBank ID
DB00303
Drug Central Database
1,046
KEGG DRUG Database
D07908
PubChem SID
85595963
Properties
No Data Available
Click here to submit data
Molecule Details
Meropenem in which the one of the two methyl groups attached to the amide nitrogen is replaced by hydrogen while the other is replaced by a 3-carboxyphenyl group. The sodium salt is used for the treatment of moderate to severe susceptible infections including intra-abdominal and acute gynaecological infections, pneumonia, and infections of the skin and of the urinary tract.
Molecular Spectra
No Data Available
Click here to submit data
References
No Data Available
Click here to submit data
Navigation